THOKALA; Radhika
Patent Applications and Registrations
Patent applications and USPTO patent grants for THOKALA; Radhika.The latest application filed is for "compositions and methods comprising a high affinity chimeric antigen receptor (car) with cross-reactivity to clinically-relevant egfr mutated proteins".
- THOKALA; Radhika - Conshohocken PA
- Thokala; Radhika - Houston TX
- Thokala; Radhika - Philadelphia PA
| Patent | Date |
|---|---|
| Compositions and Methods Comprising a High Affinity Chimeric Antigen Receptor (CAR) with Cross-Reactivity to Clinically-Relevant EGFR Mutated Proteins App 20220184129 - O'ROURKE; Donald ; et al. | 2022-06-16 |
| Chimeric antigen receptor molecules and uses thereof Grant 11,059,879 - Thokala , et al. July 13, 2 | 2021-07-13 |
| SYNTHETIC CARS TO TREAT IL13R-alpha-2 POSITIVE HUMAN AND CANINE TUMORS App 20210128617 - O'Rourke; Donald M. ; et al. | 2021-05-06 |
| Chimeric Antigen Receptor Molecules And Uses Thereof App 20190055299 - THOKALA; Radhika ; et al. | 2019-02-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 